Structural insights into mechanisms of non-nucleoside drug resistance for HIV-1 reverse transcriptases mutated at codons 101 or 138.
Ren, J., Nichols, C.E., Stamp, A., Chamberlain, P.P., Ferris, R., Weaver, K.L., Short, S.A., Stammers, D.K.(2006) FEBS J 273: 3850-3860
- PubMed: 16911530 
- DOI: 10.1111/j.1742-4658.2006.05392.x
- Primary Citation of Related Structures:  
2HND, 2HNZ, 2HNY - PubMed Abstract: 
Lys101Glu is a drug resistance mutation in reverse transcriptase clinically observed in HIV-1 from infected patients treated with the non-nucleoside inhibitor (NNRTI) drugs nevirapine and efavirenz. In contrast to many NNRTI resistance mutations, Lys101( ...